The spleen in hematologic malignancies;Die milz bei hämato-onkologischen erkrankungen

Therapeutische Umschau

Volumn 70, Issue 3, 2013, Pages 163-169

  Kienle, Dirk L ^a  

^a Kantonsspital Graubünden ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOMA; MYELOPROLIFERATIVE NEOPLASM; SPLEEN; SPLENOMEGALY;

HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HUMANS; SPLEEN; SPLENECTOMY;

EID: 84874754357     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000385     Document Type: Article

References (7)

1. O'Reilly RA. Splenomegaly in 2,505 Patients at a Large University Medical Center From 1913 to 1995. West J Med 1998; 169: 88-97.
2. Kraus MD, Fleming MD, Vonderheide RH. The spleen as a diagnostic specimen: a review of 10 years' experience at two tertiary care institutions. Cancer. 2001; 91: 2001.
3. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS.Clinical staging of chronic lymphocytic leukemia. Blood. 1975; 46: 219.
4. Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981; 48: 198.
5. Hallek M, Cheson B, Catovsky D et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute- Working Group 1996 guidelines. Blood. 2008; 111: 5446-5456.
6. Vardiman W, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009; 114: 937-951.
7. Gangat N, Caramazza D, Vaidya R et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol. 2011; 29: 392.